Zobrazeno 1 - 10
of 30
pro vyhledávání: '"A. V. Kamynina"'
Publikováno v:
Медицинский совет, Vol 0, Iss 8, Pp 118-125 (2022)
Introduction. There is an abundance of various methods of surgical treatment in the world, which include: classical tonsillectomy (TE), shaver TE, unipolar and bipolar bilateral TE, laser TE, palatine tonsil coblation, etc. However, there is still a
Externí odkaz:
https://doaj.org/article/c0fa9c1b4ce04973859fe6d7e196e17a
Autor:
Anatoly S. Urban, Konstantin V. Pavlov, Anna V. Kamynina, Ivan S. Okhrimenko, Alexander S. Arseniev, Eduard V. Bocharov
Publikováno v:
Molecules, Vol 26, Iss 10, p 2897 (2021)
Alzheimer’s disease is the most common type of neurodegenerative disease in the world. Genetic evidence strongly suggests that aberrant generation, aggregation, and/or clearance of neurotoxic amyloid-β peptides (Aβ) triggers the disease. Aβ accu
Externí odkaz:
https://doaj.org/article/467b0090289a49c7a051faa36381a146
Autor:
Anna V. Kamynina, Noemi Esteras, Dmitriy O. Koroev, Natalia V. Bobkova, Samson M. Balasanyants, Ruben A. Simonyan, Armine V. Avetisyan, Andrey Y. Abramov, Olga M. Volpina
Publikováno v:
Frontiers in Neuroscience, Vol 12 (2018)
Receptor for advanced glycation end products (RAGE) is involved in the pathogenesis of Alzheimer’s disease. We have previously revealed that RAGE fragment sequence (60–76) and its shortened analogs sequence (60–70) and (60–65) under intranasa
Externí odkaz:
https://doaj.org/article/12adc6fa2f204f1cb64436681b897176
Autor:
Plamena R. Angelova, A. V. Kamynina, Olga M. Volpina, Andrey Y. Abramov, Noemí Esteras, D. O. Koroev
Publikováno v:
Journal of Cellular Physiology
The receptor for advanced glycation end products (RAGE) is a signal receptor first shown to be activated by advanced glycation end products, but also by a variety of signal molecules, including pathological advanced oxidation protein products and β
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::945e8d897d55559eace0f330ec85d378
https://doi.org/10.1002/jcp.30324
https://doi.org/10.1002/jcp.30324
Autor:
T. D. Volkova, D. O. Koroev, A. V. Kamynina, A. V. Avetisyan, Olga M. Volpina, M. P. Filatova
Publikováno v:
Russian Journal of Bioorganic Chemistry. 46:217-222
The solid-phase synthesis and purification of the 1-40 sequence of the human beta-amyloid were optimized, resulting in a preparation of a product with a high yield and homogeneity more than 95%. The synthetic peptide is capable of forming oligomers.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0ab6f0075f04e61c224e0fa1d7d724a
https://doi.org/10.1134/s1068162020020181
https://doi.org/10.1134/s1068162020020181
Autor:
Eduard V, Bocharov, Lothar, Gremer, Anatoly S, Urban, Ivan S, Okhrimenko, Pavel E, Volynsky, Kirill D, Nadezhdin, Olga V, Bocharova, Daniil A, Kornilov, Yuliya A, Zagryadskaya, Anna V, Kamynina, Pavel K, Kuzmichev, Janine, Kutzsche, Najoua, Bolakhrif, Andreas, Müller-Schiffmann, Norbert A, Dencher, Alexander S, Arseniev, Roman G, Efremov, Valentin I, Gordeliy, Dieter, Willbold
Publikováno v:
Journal of medicinal chemistry. 64(22)
Alzheimer's disease (AD) is a severe neurodegenerative pathology with no effective treatment known. Toxic amyloid-β peptide (Aβ) oligomers play a crucial role in AD pathogenesis. All
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5734610a5dba17c95b40542793d2c19e
https://pubmed.ncbi.nlm.nih.gov/34739758
https://pubmed.ncbi.nlm.nih.gov/34739758
Autor:
E. V. Ponomareva, D. O. Koroev, A. V. Kamynina, Olga M. Volpina, I. V. Kolykhalov, Ya. B. Fedorova, Selezneva Nd, Gavrilova Si
Publikováno v:
Neuroscience and Behavioral Physiology. 49:523-534
Objectives. Therapeutic monitoring and evaluation of the efficacy of neurotrophic therapy in patients with amnestic-type mild cognitive decline syndrome (aMCI) were performed in a model using courses of cerebrolysin. Materials and methods. A total of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51dc0306b7a93c88381ec917e4e56043
https://doi.org/10.1007/s11055-019-00765-5
https://doi.org/10.1007/s11055-019-00765-5
Autor:
T. D. Volkova, D. O. Koroev, Natalia V. Bobkova, Marina V. Serebryakova, A. V. Kamynina, Olga M. Volpina
Publikováno v:
Drug development researchREFERENCES. 82(8)
The receptor for advanced glycation end products (RAGE) plays an essential role in Alzheimer's disease (AD). We previously demonstrated that a fragment (60-76) of RAGE improved the memory of olfactory bulbectomized (OBX) and Tg 5 × FAD mice - animal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcd021d46f91e4e0a9ff5d7a7efd2f34
https://pubmed.ncbi.nlm.nih.gov/34060112
https://pubmed.ncbi.nlm.nih.gov/34060112
Autor:
A. V. Kamynina, D. O. Koroev, Michala Kolarova, Daniela Ripova, Olga M. Volpina, Jan Ricny, Ales Bartos
Publikováno v:
SOJ Immunology. 4:1-4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2174da6a4d250a8b8b8bf10a1473675
https://doi.org/10.15226/2372-0948/4/2/00149
https://doi.org/10.15226/2372-0948/4/2/00149
Autor:
Samson M. Balasanyants, Andrey Y. Abramov, A. V. Kamynina, Ruben A. Simonyan, Olga M. Volpina, A. V. Avetisyan, D. O. Koroev, Noemí Esteras, Natalia V. Bobkova
Publikováno v:
Frontiers in Neuroscience, Vol 12 (2018)
Frontiers in Neuroscience
Frontiers in Neuroscience
Receptor for advanced glycation end products (RAGE) is involved in the pathogenesis of Alzheimer's disease. We have previously revealed that RAGE fragment sequence (60-76) and its shortened analogs sequence (60-70) and (60-65) under intranasal insert
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75c40c5cdfd1e292ffeda9ef4487bf44
https://www.frontiersin.org/article/10.3389/fnins.2018.00681/full
https://www.frontiersin.org/article/10.3389/fnins.2018.00681/full